financetom
Business
financetom
/
Business
/
Hugo Boss sells Russian business to wholesale partner Stockmann
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hugo Boss sells Russian business to wholesale partner Stockmann
Aug 5, 2024 12:52 AM

(Reuters) - Hugo Boss has sold its Russian business to wholesale partner Stockmann for an undisclosed fee, the German fashion house said on Monday, joining the ranks of Western brands to exit the Russian market over the war in Ukraine.

The German fashion company suspended its retail business in Russia soon after Moscow invaded Ukraine in February 2022. It also paused its e-commerce activities in the Russian market and stopped advertising.

"We can confirm that our Russian subsidiary has been sold to Stockmann JSC - a company belonging to one of Hugo Boss's long-standing wholesale partners in the country," Hugo Boss said.

Neither party has disclosed financial terms of the deal, but Russia demands that foreign companies sell assets at discounts of at least 50%. Stockmann did not respond immediately to a request for comment.

Russian corporate filings showed that the deal closed on Aug. 2 and that Stockmann JSC now owns 100% of Hugo Boss Rus with a nominal value of 40 million roubles ($470,588).

Hugo Boss had come under pressure from organisations such as B4Ukraine for continuing to supply some goods to Russia. B4Ukraine is a coalition of civil society groups seeking to compel Western companies to sever ties with Russia.

"In terms of our wholesale business, we were fulfilling the contractual obligations to our partners," Hugo Boss said in April. "In this context, Hugo Boss is and has been complying with existing EU sanctions at all times."

Stockmann in Russia operates independently to its former Finnish owner, which sold its Russian business after Moscow's 2014 annexation of Crimea.

($1 = 85.0000 roubles)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EXCLUSIVE: 3 Famed Cannabis Genetics Providers Announce Merger And Initial Public Offering
EXCLUSIVE: 3 Famed Cannabis Genetics Providers Announce Merger And Initial Public Offering
Dec 4, 2024
The legendary global seed bank headquartered in Amsterdam, Barney's Farm Genetics has entered an agreement to merge with Sensi Seeds, a pioneering international seed library and the California-based online marijuana seed bank I Love Growing Marijuana (ILGM). The announcement took place at MJ BizCon, the world's leading annual cannabis conference and trade show, in Las Vegas, Nevada. 2025 will be...
Snoop Dogg helps Publicis claim world's largest ad group title
Snoop Dogg helps Publicis claim world's largest ad group title
Dec 4, 2024
LONDON (Reuters) - France's Publicis has enlisted Snoop Dogg, the American rapper who became a breakout star at the Paris Olympics, to help it celebrate overtaking British rival WPP ( WPP ) as the world's largest ad group in 2024. Snoop Dogg was seen everywhere at the Olympics, from carrying the torch to dressing in riding gear at equestrian events...
Cross Country Healthcare to be Acquired by Aya Healthcare and Taken Private for $18.61 per Share in Cash
Cross Country Healthcare to be Acquired by Aya Healthcare and Taken Private for $18.61 per Share in Cash
Dec 4, 2024
08:14 AM EST, 12/04/2024 (MT Newswires) -- Cross Country Healthcare (CCRN) and Aya Healthcare said Wednesday they signed an agreement under which Aya will acquire Cross Country Healthcare ( CCRN ) for $18.61 per share in cash for roughly $615 million in transaction value. The transaction, expected to be completed in H1 next year, has been unanimously approved by Cross...
Stoke Therapeutics' Zorevunersen Gets FDA Breakthrough Therapy Status in Dravet Syndrome
Stoke Therapeutics' Zorevunersen Gets FDA Breakthrough Therapy Status in Dravet Syndrome
Dec 4, 2024
08:11 AM EST, 12/04/2024 (MT Newswires) -- Stoke Therapeutics ( STOK ) said Wednesday it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for zorevunersen as treatment for Dravet syndrome with a confirmed mutation in the SCN1A gene. Phase 1/2a and open-label extension studies of zorevunersen showed substantial and sustained reductions in seizure frequency and improvements...
Copyright 2023-2026 - www.financetom.com All Rights Reserved